XIE Bin, LIU Jie, CHEN Xinmin, YANG Peixin, YANG Qiong, LU Sisi, CAI Jinlan, ZHONG Kefeng. Study on the Bioequivalence of Itopride Hydrochloride Tablets in Healthy Subjects[J]. Chinese Journal of Modern Applied Pharmacy, 2022, 39(16): 2145-2150. DOI: 10.13748/j.cnki.issn1007-7693.2022.16.016
    Citation: XIE Bin, LIU Jie, CHEN Xinmin, YANG Peixin, YANG Qiong, LU Sisi, CAI Jinlan, ZHONG Kefeng. Study on the Bioequivalence of Itopride Hydrochloride Tablets in Healthy Subjects[J]. Chinese Journal of Modern Applied Pharmacy, 2022, 39(16): 2145-2150. DOI: 10.13748/j.cnki.issn1007-7693.2022.16.016

    Study on the Bioequivalence of Itopride Hydrochloride Tablets in Healthy Subjects

    • OBJECTIVE To evaluate the bioequivalence of itopride hydrochloride tablets.METHODS The concentration of itopride in plasma was measured by HPLC-MS/MS.Sixty-four healthy subjects (32 on fasting and 32 after meal) were randomly assigned to take a single dose of itopride hydrochloride tablets 50 mg orally as test preparation and reference preparation.The plasma concentrations of itopride hydrochloride tablets were determined at different times and the pharmacokinetic parameters were calculated by Phoenix WinNonlin software.RESULTS Under fasting conditions,the 90% confidence intervals of Cmax,AUC0-t and AUC0-∞ for the test/reference geometric mean ratio were 89.42%-118.95%,93.25%-117.27%,92.78%-117.33%.Under fed conditions,the 90% confidence intervals of Cmax,AUC0-t and AUC0-∞ for the test/reference geometric mean ratio were 90.53%-104.83%,96.72%-99.77%,96.76%-99.88%.CONCLUSION The test preparation and reference preparation of itopride hydrochloride tablets are bioequivalent.
    • loading

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return